Search research articles
Contact Us
Filters
Showing results (41-50 of 66) with videos related to
Page
of 7
Sort By:
JCO Precision Oncology
|
February 1, 2022
Multimodal Approach to Outcome Prediction in Metastatic Castration-Resistant Prostate Cancer by Integrating Functional Imaging and Plasma DNA Analysis
Vincenza Conteduca, Emanuela Scarpi, Federica Matteucci, et al.
BMC Medicine
|
February 1, 2022
Circulating tumor cell gene expression and plasma AR gene copy number as biomarkers for castration-resistant prostate cancer patients treated with cabazitaxel
Giorgia Gurioli, Vincenza Conteduca, Nicole Brighi, et al.
Frontiers in Oncology
|
October 19, 2020
Potential Application of Chimeric Antigen Receptor (CAR)-T Cell Therapy in Renal Cell Tumors
Giuseppe Schepisi, Vincenza Conteduca, Chiara Casadei, et al.
Frontiers in Oncology
|
June 27, 2022
Inflammatory Biomarkers for Outcome Prediction in Patients With Metastatic Testicular Cancer
Sara Bleve, Maria Concetta Cursano, Chiara Casadei, et al.
The Prostate
|
April 22, 2017
Long-term clinical impact of PSA surge in castration-resistant prostate cancer patients treated with abiraterone
Vincenza Conteduca, Orazio Caffo, Cristian Lolli, et al.
Scientific Reports
|
October 20, 2018
Plasma androgen receptor and serum chromogranin A in advanced prostate cancer
Vincenza Conteduca, Emanuela Scarpi, Samanta Salvi, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 29, 2024
Correlation of [<sup>68</sup>Ga]Ga-PSMA PET/CT response and PSA decline in first-line enzalutamide for metastatic castration-resistant prostate cancer patients
Emilio Francesco Giunta, Paola Caroli, Emanuela Scarpi, et al.
Frontiers in Oncology
|
September 4, 2023
Impact of the time interval between primary or interval surgery and adjuvant chemotherapy in ovarian cancer patients
Alberto Farolfi, Elisabetta Petracci, Giorgia Gurioli, et al.
Cancers
|
November 7, 2019
Plasma Androgen Receptor in Prostate Cancer
Vincenza Conteduca, Giorgia Gurioli, Nicole Brighi, et al.
BMC Cancer
|
December 21, 2018
Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer
Vincenza Conteduca, Giorgia Gurioli, Lorena Rossi, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 66) with videos related to
Sort By:
Page
of 7
JCO Precision Oncology
|
February 1, 2022
Multimodal Approach to Outcome Prediction in Metastatic Castration-Resistant Prostate Cancer by Integrating Functional Imaging and Plasma DNA Analysis
Vincenza Conteduca, Emanuela Scarpi, Federica Matteucci, et al.
BMC Medicine
|
February 1, 2022
Circulating tumor cell gene expression and plasma AR gene copy number as biomarkers for castration-resistant prostate cancer patients treated with cabazitaxel
Giorgia Gurioli, Vincenza Conteduca, Nicole Brighi, et al.
Frontiers in Oncology
|
October 19, 2020
Potential Application of Chimeric Antigen Receptor (CAR)-T Cell Therapy in Renal Cell Tumors
Giuseppe Schepisi, Vincenza Conteduca, Chiara Casadei, et al.
Frontiers in Oncology
|
June 27, 2022
Inflammatory Biomarkers for Outcome Prediction in Patients With Metastatic Testicular Cancer
Sara Bleve, Maria Concetta Cursano, Chiara Casadei, et al.
The Prostate
|
April 22, 2017
Long-term clinical impact of PSA surge in castration-resistant prostate cancer patients treated with abiraterone
Vincenza Conteduca, Orazio Caffo, Cristian Lolli, et al.
Scientific Reports
|
October 20, 2018
Plasma androgen receptor and serum chromogranin A in advanced prostate cancer
Vincenza Conteduca, Emanuela Scarpi, Samanta Salvi, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 29, 2024
Correlation of [<sup>68</sup>Ga]Ga-PSMA PET/CT response and PSA decline in first-line enzalutamide for metastatic castration-resistant prostate cancer patients
Emilio Francesco Giunta, Paola Caroli, Emanuela Scarpi, et al.
Frontiers in Oncology
|
September 4, 2023
Impact of the time interval between primary or interval surgery and adjuvant chemotherapy in ovarian cancer patients
Alberto Farolfi, Elisabetta Petracci, Giorgia Gurioli, et al.
Cancers
|
November 7, 2019
Plasma Androgen Receptor in Prostate Cancer
Vincenza Conteduca, Giorgia Gurioli, Nicole Brighi, et al.
BMC Cancer
|
December 21, 2018
Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer
Vincenza Conteduca, Giorgia Gurioli, Lorena Rossi, et al.
Page
of 7